Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:1024
SEHK:1024Interactive Media and Services

A Look At Kuaishou Technology’s (SEHK:1024) Valuation After Recent Share Price Weakness

Setting the scene for Kuaishou Technology Kuaishou Technology (SEHK:1024) has drawn investor attention after a period of weak share price performance, with the stock showing negative returns over the past month, past 3 months, and year to date. See our latest analysis for Kuaishou Technology. At a latest share price of HK$43.7, Kuaishou’s weak recent momentum, including a 30 day share price return of 17.62% decline and a 1 year total shareholder return of 13.33% decline, points to fading...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Assessing T. Rowe Price (TROW) Valuation After Expanded 55ip Tax Optimization Partnership

Fresh attention is turning to T. Rowe Price Group (TROW) after 55ip, a J.P. Morgan subsidiary, expanded its collaboration with the asset manager to deliver tax-focused custom model portfolios for financial advisors. See our latest analysis for T. Rowe Price Group. The dual-share class approval and the expanded 55ip partnership come as T. Rowe Price Group’s share price sits at US$99.49, with a 12.04% 1 month share price return but a 5 year total shareholder return of negative 31.28%. This...
NYSE:KMI
NYSE:KMIOil and Gas

Kinder Morgan (KMI) Margin Strength And 17% Earnings Growth Test Bullish Narratives

Kinder Morgan (KMI) opened 2026 with Q1 results that build on a solid recent run, with Q4 2025 revenue at US$4.5 billion and basic EPS of US$0.45 supported by net income of US$991 million. Over the past few quarters, revenue has moved from US$3.7 billion in Q3 2024 to US$4.0 billion in Q2 2025 and US$4.5 billion in Q4 2025, while basic EPS shifted from US$0.28 to US$0.32 and then to US$0.45. Together, these figures give you a clear sense of the recent earnings trajectory. With a trailing net...
TSE:7974
TSE:7974Entertainment

Nintendo (TSE:7974) Is Down 7.5% After Cutting Switch 2 Output Amid Rising Memory Costs – What's Changed

Nintendo recently reported rising memory component costs that it cannot pass on to customers, pressuring margins and forcing a cut in quarterly Switch 2 production from 6 million to 4 million units amid softer demand. An interesting angle is that, despite these operational headwinds, the company is leaning on its sizeable cash reserves to support its longer-term business plans. We’ll now explore how rising memory costs and reduced Switch 2 production are shaping Nintendo’s investment...
NYSE:NLY
NYSE:NLYMortgage REITs

Is It Too Late To Consider Annaly Capital Management (NLY) After Its Recent Share Price Run?

If you are wondering whether Annaly Capital Management's share price still reflects fair value after a strong run, this article walks through what the current numbers may be saying about the stock. The stock last closed at US$22.43, with returns of 1.3% over 7 days, 6.4% over 30 days, a 2.1% decline year to date, 35.7% over 1 year, 70.0% over 3 years and 21.4% over 5 years. Recent coverage has focused on Annaly Capital Management's position within the mortgage REIT space and how interest...
NYSE:WEC
NYSE:WECIntegrated Utilities

Is It Too Late To Consider WEC Energy Group (WEC) After Recent Utility Sector Focus?

Wondering if WEC Energy Group at around US$115.57 is offering fair value or if you are paying up for a premium utility stock? This article unpacks the numbers so you can judge how its current price compares across several valuation lenses. The stock has returned 2.2% over the last 30 days and 8.5% year to date, with a 9.7% return over the past year and longer-term gains of 33.3% over 3 years and 42.7% over 5 years. Recent attention on utilities and power infrastructure has kept investor...
AIM:CRDL
AIM:CRDLSoftware

UK Penny Stocks To Watch In April 2026

The UK market has been facing challenges, with the FTSE 100 index recently closing lower due to weak trade data from China, highlighting concerns about global economic recovery. Despite such headwinds, the search for investment opportunities continues, and penny stocks remain an intriguing area for investors seeking potential growth. While the term 'penny stocks' might seem outdated, these smaller or newer companies can still offer substantial value when they possess strong financial...
NYSE:WAL
NYSE:WALBanks

Western Alliance Addresses Fraud Losses And Resets Deposit Growth And Valuation

Western Alliance Bancorporation (NYSE:WAL) addressed two significant fraud-related loan charge-offs in Q1 2026, which management believes helps clear legacy credit risk. The bank reported $5.6b in Q1 deposit growth and plans to shift from aggressive deposit gathering to a more balanced growth approach. These moves are intended to refine Western Alliance's risk management and funding profile following a period of strong deposit inflows. Western Alliance Bancorporation enters this shift with...
TSX:ONEX
TSX:ONEXCapital Markets

Is Onex (TSX:ONEX) Fairly Valued After Its Recent Share Price Momentum

Why Onex is on investors’ radar now Onex (TSX:ONEX) has drawn attention after recent share price moves, with the stock showing positive returns over the past month and past 3 months, prompting investors to reassess its diversified private equity model. See our latest analysis for Onex. The recent 30 day share price return of 17.97% and 1 year total shareholder return of 22.52%, alongside a 91.05% total shareholder return over 3 years, point to momentum that has built over time rather than a...
NasdaqGS:EZPW
NasdaqGS:EZPWConsumer Finance

EZCORP (EZPW) Is Up 5.8% After Record FY2024 Results And Pawn Loan Growth - Has The Bull Case Changed?

In its recently reported fiscal Q4 and full-year 2024 results, EZCORP announced record revenue and EBITDA margins, 11% year-over-year Q4 revenue growth, a 14% increase in pawn loans outstanding, and the addition of 21 stores across five countries. Management also highlighted rapid uptake of EZ+ Rewards and online payment options alongside a strong mergers-and-acquisitions pipeline, signaling an intensified push to scale both its physical footprint and digital customer channels. We’ll now...
NYSE:MNSO
NYSE:MNSOMultiline Retail

A Look At MINISO Group Holding’s Valuation As The CEO Plans A HK$50 Million Share Purchase

MINISO Group Holding (MNSO) has drawn fresh attention after Chairman and CEO Guofu Ye announced plans to buy at least HK$50.0 million of shares with personal funds over the next year. See our latest analysis for MINISO Group Holding. Despite the chairman’s planned HK$50.0 million share purchase, recent momentum has been weak. The latest 30 day share price return of 11.26% and a 1 year total shareholder return of 12.34% point to fading gains. If this insider move has you rethinking where...
ENXTAM:BESI
ENXTAM:BESISemiconductor

BESI (ENXTAM:BESI) Margin Compression Tests High P/E Growth Story Heading Into Q1 2026

BE Semiconductor Industries (ENXTAM:BESI) has just opened Q1 2026 earnings season with recent quarterly numbers that put hard figures around the current debate, with Q4 2025 revenue at €166.4 million and basic EPS at €0.54, set against a trailing twelve month picture that includes total revenue of €591.3 million and EPS of €1.66. Over the past six reported quarters, the company has seen revenue move from €153.4 million in Q4 2024 to €166.4 million in Q4 2025, while quarterly basic EPS shifted...
NYSE:FLR
NYSE:FLRConstruction

Fluor’s Shift To Reimbursable Contracts And NuScale Monetization Might Change The Case For Investing In Fluor (FLR)

Fluor Corporation recently advanced its transformation from a fixed-price engineering and construction contractor to a more predictable reimbursable-services platform, rebuilding its backlog with higher-quality, lower-volatility contracts. An interesting development is that Fluor is funding a large share repurchase program partly by monetizing its NuScale stake, aiming to make earnings more capital-efficient and shareholder-focused. We’ll now examine how Fluor’s pivot toward reimbursable,...
NasdaqGS:SYRE
NasdaqGS:SYREBiotechs

A Look At Spyre Therapeutics (SYRE) Valuation After Positive SKYLINE Data And Strong Buy Analyst Initiation

Spyre Therapeutics (SYRE) is back on investors' radar after reporting positive 12-week induction data from Part A of its Phase 2 SKYLINE trial for SPY001 in moderate to severely active ulcerative colitis. See our latest analysis for Spyre Therapeutics. The positive SKYLINE data landed alongside a $403 million follow on equity offering. Despite a 5.15% 1 day share price decline to $69.24, Spyre still shows a 64.0% 30 day share price return and a very large 3 year total shareholder return. This...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Is JDcom (NasdaqGS:JD) Still Attractive After Recent Share Price Rebound

If you are wondering whether JD.com's current share price still offers value or if most of the opportunity is already priced in, this article breaks down what the market is paying for and what that might mean for you. The stock closed at US$29.98, with a 9.1% gain over 30 days, a 4.3% decline over 7 days, a 1.5% return year to date, and longer term returns of a 4.4% decline over 1 year, a 5.6% decline over 3 years, and a 56.2% decline over 5 years. Recent coverage around JD.com has focused...
NYSE:ITT
NYSE:ITTMachinery

Assessing ITT (ITT) Valuation After Strong Recent Share Price Momentum

Why ITT (ITT) Is On Investors’ Radar Today ITT (ITT) has drawn attention after recent share price strength, with the stock closing at $219.10 and showing positive returns over the past week, month and past 3 months. With a market value of about $19.4b and a footprint across transportation, industrial and energy markets, the company’s recent performance is prompting investors to reassess how current pricing lines up with its fundamentals. See our latest analysis for ITT. ITT’s recent share...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Is It Too Late To Consider Cytokinetics (CYTK) After Its 62% One-Year Surge?

Investors may be wondering whether Cytokinetics at around US$65.48 is still offering value, or if most of the upside is already reflected in the price. The stock has returned 0.1% over the last week, 9.1% over the past 30 days, 6.1% year to date and 62.4% over the last year, with longer term returns of 73.0% over 3 years and 148.1% over 5 years. Recent coverage has focused on Cytokinetics as a biotech name that investors are watching closely, with attention on how its pipeline and...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron’s Wheatstone Restart And Venezuela Shift Versus Current Valuation

Chevron has resumed full production at its Wheatstone LNG facility in Australia after repairs related to cyclone damage. The company has completed an asset swap in Venezuela that increases its stake in heavy oil operations. Both moves come as global energy trade is being reshaped by geopolitical tension and shifting supply routes. For investors tracking NYSE:CVX, these operational updates arrive with the stock trading at $187.6 and showing a 20.3% return year to date and 41.0% over the past...
NYSE:CNC
NYSE:CNCHealthcare

Is It Time To Reassess Centene (CNC) After Its Recent Share Price Rebound

Investors may be asking whether Centene's current share price reflects its true worth, or if the recent weakness could be setting up a more interesting entry point. Centene's stock closed at US$41.09, with a 5.4% gain over the last 7 days and a 24.6% gain over the last 30 days, while returns sit at a 1.7% decline year to date and a 33.3% decline over the past year. Recent news around Centene has focused on its position in managed care and healthcare services, as investors weigh how policy,...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

Assessing CareDx (CDNA) Valuation As Recent Share Price Swings Draw Investor Attention

Why CareDx Stock Is on Investors’ Radar Now CareDx (CDNA) has drawn attention after recent share price swings, with a 2.8% decline over the past day, a 10.5% drop over the past week, and a 12.4% gain over the past month. See our latest analysis for CareDx. Beyond the latest swings, CareDx’s 1 month share price return of 12.44% contrasts with a 4.81% year to date share price gain. The 3 year total shareholder return is very large, suggesting sentiment has shifted more meaningfully over a...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Corpay’s Toulouse FC Deal And What It Could Mean For NYSE CPAY

Corpay Cross-Border, part of NYSE:CPAY, has entered a new partnership with Toulouse Football Club as the club's Official FX Supplier. The agreement extends Corpay's reach in European football, following its previously announced relationship with AC Milan. The deal focuses on supporting Toulouse FC's international payment and currency risk management needs. For readers tracking NYSE:CPAY, this Toulouse FC partnership adds another high profile sports relationship to Corpay's cross border...
NYSE:PFS
NYSE:PFSBanks

How Investors Are Reacting To Provident Financial Services (PFS) Share Buyback And Digital Upgrade Plans

Earlier this year, Provident Financial Services reported a strong fourth quarter with record pre-provision net revenue, improved profitability, and board approval for a new repurchase authorization of up to 2 million shares. The company also highlighted plans to keep investing in revenue-producing talent and to complete a major core system conversion in fall 2026 to strengthen scalability and digital capabilities. Next, we’ll examine how the new share repurchase authorization could influence...
ASX:ALK
ASX:ALKMetals and Mining

Alkane Resources Cash Build And Index Entry After Record Gold Quarter

Alkane Resources (ASX:ALK) reports record quarterly gold equivalent production. The company generates strong operating cash flow in the same quarter. Alkane Resources is added to the S&P/ASX 200 Index, lifting its market profile. Alkane Resources, a gold producer listed on the ASX under the ticker ASX:ALK, has released an update that combines record quarterly output with solid cash generation. The company is now also included in the S&P/ASX 200 Index, which brings it into a broader group of...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Goosehead Insurance (GSHD) Margin Pressure Tests Bullish Growth Narrative Ahead Of Q1 2026

Goosehead Insurance (GSHD) has just posted its latest update for Q1 2026, with recent quarterly numbers showing Q4 2025 revenue of US$105.1 million and basic EPS of US$0.50 on net income of US$12.4 million. Over the past reported periods, revenue has moved from US$77.8 million in Q3 2024 to US$93.7 million in Q4 2024 and then to US$105.1 million in Q4 2025, while basic EPS over the same snapshot has been US$0.31, US$0.60 and US$0.50 respectively. This gives a clearer sense of how the top line...